OncoFirm PSA Rapid Test
$520.00
OncoScreen-PSA™ – Rapid Lateral Flow Test Kit
PSA Prostate Specific Antigen Semi-Quantitative Ultra Rapid Test Device (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for semi-quantitative detection of Prostate Specimen Antigen in whole blood, serum or plasma.
Early Detection. Improved Outcomes. At the Point of Care.
100 in stock
Description
OncoFirm-PSA Rapid Test for Prostate-Specific Antigen (PSA) Detection
Overview:
OncoFirm-PSA is a fast, reliable, and easy-to-use rapid test for the detection of elevated Prostate-Specific Antigen (PSA) levels—an important biomarker in the early identification and monitoring of prostate cancer. Developed using OncoFirm’s advanced lateral flow assay (LFA) technology, this test provides results within 15 minutes, empowering healthcare professionals to screen patients at the point of care without the need for lab infrastructure.
Front Panel (Main Messaging)
- OncoFirm Diagnostics
- Early Rapid Cancer Screening Test
- Detect Early. Save Lives.
- Fast & Reliable Results
- Easy-to-Use Lateral Flow Cassette
- For Professional Use / Point-of-Care Settings
Side Panel (Product Highlights or Benefits)
- Results in <15 minutes
- High-sensitivity cancer biomarkers
- No lab equipment required
- Supports early intervention and treatment planning
- Back Panel (Instructions/Compliance)
Intended Use:
This test is designed for the qualitative detection of tumor-associated biomarkers in human serum or whole blood. For use by healthcare professionals.
Storage: Store at 2–30°C. Do not freeze.
Regulatory: CE-IVDR Pending | FDA 510(k) Submission in Progress
Manufactured by: OncoFirm Diagnostics Corporation
[131 Continental Dr, Suite 305, City of Newark, County of New Castle, Delaware 19713] | [www.OncoFirm.com] | [info@oncofirm.com]
Additional information
| Format | Whole Blood, Serum, Plasma |
|---|
You must be logged in to post a review.
Reviews
There are no reviews yet.